Alexion, AstraZeneca Rare Disease (Alexion, AstraZeneca Rare Disease)

Lobbying Organisation Alexion, AstraZeneca Rare Disease

Date published 05 May, 2026

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan. 2026 to 30 Apr. 2026

Specific Details Alexion - Biomethane Carbon AMS gas connectivity

Intended results Maintain progress with timelines for grid connectivity of biomethane plant in Duleek to serve Alexion sites in Ireland

Name of person primarily responsible for lobbying on this activity Andrew Brown; Mike O'Donnell; Brian Mulchinock

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Conference Call (2-5)

Series of virtual calls on matter and liaison with Gas Network Ireland

Email (2-5)

Status updates on dialogue and progress with Gas Network Ireland

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Siobhan Russell Special Adviser (Department of Climate, Energy and the Environment)

Sean Kinsella Head of Directorate (Department of Climate, Energy and the Environment)